Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.
2.

Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).

Michaels JA, Campbell WB, Brazier JE, Macintyre JB, Palfreyman SJ, Ratcliffe J, Rigby K.

Health Technol Assess. 2006 Apr;10(13):1-196, iii-iv. Review.

3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
4.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

5.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

6.

Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.

Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, Fisher P, Van Haselen R, Wonderling D, Grieve R.

Health Technol Assess. 2004 Nov;8(48):iii, 1-35. Review.

7.

Does early imaging influence management and improve outcome in patients with low back pain? A pragmatic randomised controlled trial.

Gilbert FJ, Grant AM, Gillan MG, Vale L, Scott NW, Campbell MK, Wardlaw D, Knight D, McIntosh E, Porter RW.

Health Technol Assess. 2004 May;8(17):iii, 1-131. Review.

8.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
9.

Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.

11.

Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations.

Wallace P, Barber J, Clayton W, Currell R, Fleming K, Garner P, Haines A, Harrison R, Jacklin P, Jarrett C, Jayasuriya R, Lewis L, Parker S, Roberts J, Thompson S, Wainwright P.

Health Technol Assess. 2004 Dec;8(50):1-106, iii-iv. Review.

12.

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.

13.

Patient management, complications, and intensive care.

Gibbons KJ, Livingston K.

Neurosurg Clin N Am. 1994 Jul;5(3):555-63. Review.

PMID:
8086806
14.

The application of decision analysis to critical care medicine.

Chalfin DB, Niederman MS, Fein AM.

Intensive Care World. 1992 Sep;9(3):120-4. Review. No abstract available.

PMID:
10148142
15.

Tonometry: part 2 clinical use and cost implications.

Fiddian-Green RG.

Intensive Care World. 1992 Sep;9(3):130-5. Review. No abstract available.

PMID:
10148143
Items per page

Supplemental Content

Write to the Help Desk